154 related articles for article (PubMed ID: 36800747)
1. Recent management trends of subependymal giant cell astrocytoma associated with tuberous sclerosis complex.
Shah Z; Tameezuddin A; Saeed Baqai MW; Shami MS
J Pak Med Assoc; 2023 Feb; 73(2):430-432. PubMed ID: 36800747
[TBL] [Abstract][Full Text] [Related]
2. Management of subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis complex (TSC): Clinical recommendations.
Jóźwiak S; Nabbout R; Curatolo P;
Eur J Paediatr Neurol; 2013 Jul; 17(4):348-52. PubMed ID: 23391693
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Clinical Outcomes for Subependymal Giant Cell Astrocytomas Treated with Laser Interstitial Thermal Therapy, Open Surgical Resection, and mTOR Inhibitors.
Boop S; Bonda D; Randle S; Leary S; Vitanza N; Crotty E; Novotny E; Friedman S; Ellenbogen RG; Durfy S; Goldstein H; Ojemann JG; Hauptman JS
Pediatr Neurosurg; 2023; 58(3):150-159. PubMed ID: 37232001
[TBL] [Abstract][Full Text] [Related]
4. Unique findings of subependymal giant cell astrocytoma within cortical tubers in patients with tuberous sclerosis complex: a histopathological evaluation.
Katz JS; Frankel H; Ma T; Zagzag D; Liechty B; Zeev BB; Tzadok M; Devinsky O; Weiner HL; Roth J
Childs Nerv Syst; 2017 Apr; 33(4):601-607. PubMed ID: 28074282
[TBL] [Abstract][Full Text] [Related]
5. Isolated subependymal giant cell astrocytoma (SEGA) in the absence of clinical tuberous sclerosis: two case reports and literature review.
Cobourn KD; Chesney KM; Mueller K; Fayed I; Tsering D; Keating RF
Childs Nerv Syst; 2024 Jan; 40(1):73-78. PubMed ID: 37658938
[TBL] [Abstract][Full Text] [Related]
6. Subependymal giant cell astrocytoma: diagnosis, screening, and treatment. Recommendations from the International Tuberous Sclerosis Complex Consensus Conference 2012.
Roth J; Roach ES; Bartels U; Jóźwiak S; Koenig MK; Weiner HL; Franz DN; Wang HZ
Pediatr Neurol; 2013 Dec; 49(6):439-44. PubMed ID: 24138953
[TBL] [Abstract][Full Text] [Related]
7. Laser interstitial thermal therapy for subependymal giant cell astrocytoma: technical case report.
Dadey DY; Kamath AA; Leuthardt EC; Smyth MD
Neurosurg Focus; 2016 Oct; 41(4):E9. PubMed ID: 27690646
[TBL] [Abstract][Full Text] [Related]
8. The burden of subependymal giant cell astrocytomas associated with tuberous sclerosis complex: results of a patient and caregiver survey.
Skalicky AM; Rentz AM; Liu Z; Wheless JW; Pelletier CL; Dunn DW; Frost MD; Nakagawa J; Magestro M; Prestifilippo J; Pashos C
J Child Neurol; 2015 Apr; 30(5):563-9. PubMed ID: 24667738
[TBL] [Abstract][Full Text] [Related]
9. Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facility.
Tomoto K; Fujimoto A; Inenaga C; Okanishi T; Imai S; Ogai M; Fukunaga A; Nakamura H; Sato K; Obana A; Masui T; Arai Y; Enoki H
BMC Neurol; 2021 Mar; 21(1):139. PubMed ID: 33784976
[TBL] [Abstract][Full Text] [Related]
10. Current trends in the management of subependymal giant cell astrocytomas in tuberous sclerosis.
Frassanito P; Noya C; Tamburrini G
Childs Nerv Syst; 2020 Oct; 36(10):2527-2536. PubMed ID: 32978642
[TBL] [Abstract][Full Text] [Related]
11. Dose-level response rates of mTor inhibition in tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Pole JD; Bouffet E; Taylor MD; Bartels U
Pediatr Blood Cancer; 2015 Oct; 62(10):1754-60. PubMed ID: 25929843
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological treatment strategies for subependymal giant cell astrocytoma (SEGA).
Ebrahimi-Fakhari D; Franz DN
Expert Opin Pharmacother; 2020 Aug; 21(11):1329-1336. PubMed ID: 32338549
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.
Franz DN; Belousova E; Sparagana S; Bebin EM; Frost M; Kuperman R; Witt O; Kohrman MH; Flamini JR; Wu JY; Curatolo P; de Vries PJ; Whittemore VH; Thiele EA; Ford JP; Shah G; Cauwel H; Lebwohl D; Sahmoud T; Jozwiak S
Lancet; 2013 Jan; 381(9861):125-32. PubMed ID: 23158522
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment of subependymal giant cell astrocytoma in tuberous sclerosis complex patients.
Kotulska K; Borkowska J; Roszkowski M; Mandera M; Daszkiewicz P; Drabik K; Jurkiewicz E; Larysz-Brysz M; Nowak K; Grajkowska W; Domańska-Pakieła D; Jóźwiak S
Pediatr Neurol; 2014 Apr; 50(4):307-12. PubMed ID: 24507694
[TBL] [Abstract][Full Text] [Related]
15. The effect of mTOR inhibition on obstructive hydrocephalus in patients with tuberous sclerosis complex (TSC) related subependymal giant cell astrocytoma (SEGA).
Weidman DR; Palasamudram S; Zak M; Whitney R; McCoy B; Bouffet E; Taylor M; Shroff M; Bartels U
J Neurooncol; 2020 May; 147(3):731-736. PubMed ID: 32285309
[TBL] [Abstract][Full Text] [Related]
16. A case of subependymal giant cell astrocytoma without tuberous sclerosis complex and review of the literature.
O'Rawe M; Chandran AS; Joshi S; Simonin A; Dyke JM; Lee S
Childs Nerv Syst; 2021 Apr; 37(4):1381-1385. PubMed ID: 32808065
[TBL] [Abstract][Full Text] [Related]
17. [Subependymal Giant Cell Astrocytoma with Tuberous Sclerosis Complex(TSC-SEGA)].
Ichikawa T; Niida Y
No Shinkei Geka; 2022 Jan; 50(1):111-121. PubMed ID: 35169091
[TBL] [Abstract][Full Text] [Related]
18. Presurgical Administration of mTOR Inhibitors in Patients with Large Subependymal Giant Cell Astrocytoma Associated with Tuberous Sclerosis Complex.
Jiang T; Du J; Raynald ; Wang J; Li C
World Neurosurg; 2017 Nov; 107():1053.e1-1053.e6. PubMed ID: 28866062
[TBL] [Abstract][Full Text] [Related]
19. Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex-Current Views on Their Pathogenesis and Management.
Gao C; Zabielska B; Jiao F; Mei D; Wang X; Kotulska K; Jozwiak S
J Clin Med; 2023 Jan; 12(3):. PubMed ID: 36769603
[TBL] [Abstract][Full Text] [Related]
20. Subependymal giant cell astrocytoma in the absence of tuberous sclerosis complex: case report.
Beaumont TL; Godzik J; Dahiya S; Smyth MD
J Neurosurg Pediatr; 2015 Aug; 16(2):134-7. PubMed ID: 25978531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
